TY - JOUR
T1 - Cannabis Use Disorder Treatment Preferences
T2 - A Pilot Survey in Current Users of Cannabis
AU - Lile, Joshua A.
AU - Turner, Brian W.
AU - Cox, David H.
AU - Bonn-Miller, Marcel O.
AU - Katz, Ned R.
AU - Shellenberg, Thomas P.
AU - Stoops, William W.
AU - Strickland, Justin C.
N1 - Funding Information:
Supported by R01 DA036550 and UL1TR001998.
Publisher Copyright:
© Wolters Kluwer Health, Inc. All rights reserved.
PY - 2023/3/1
Y1 - 2023/3/1
N2 - Objectives Highly effective treatments for cannabis use disorder (CUD) are lacking, and patient preferences have not been considered during treatment development. We therefore conducted an exploratory crowdsourced survey of individuals reporting current cannabis use and a willingness to cut down or quit their cannabis use, to determine their interest in various treatment aspects. Methods Subjects (n = 63) were queried about their willingness to take medications as a function of type, route, and regimen and to participate in adherence monitoring. Subjects were also asked about their willingness to engage in behavioral/psychosocial interventions as a function of type, setting, and duration. Measures theorized to be associated with treatment preferences were also collected, including cannabis use variables, readiness to change, reduction or cessation goal, perceived cessation barriers, and medication use beliefs and behaviors. Results Survey responses indicated that efforts to develop CUD medications should focus on nonsynthetic compounds administered orally or by mouth spray no more than once per day to maximize patient acceptance. Remote adherence monitoring and one-on-one outpatient behavioral treatment approaches, especially contingency management, are also anticipated to enhance participation. Most subjects indicated a preference to reduce their cannabis use rather than quit. Conclusions These data provide guidance for the development of CUD interventions based on the preferences of individuals interested in treatment for their cannabis use. Additional research is needed to confirm these results in a larger sample and determine if matching CUD patients with their preferred treatments improves success rates.
AB - Objectives Highly effective treatments for cannabis use disorder (CUD) are lacking, and patient preferences have not been considered during treatment development. We therefore conducted an exploratory crowdsourced survey of individuals reporting current cannabis use and a willingness to cut down or quit their cannabis use, to determine their interest in various treatment aspects. Methods Subjects (n = 63) were queried about their willingness to take medications as a function of type, route, and regimen and to participate in adherence monitoring. Subjects were also asked about their willingness to engage in behavioral/psychosocial interventions as a function of type, setting, and duration. Measures theorized to be associated with treatment preferences were also collected, including cannabis use variables, readiness to change, reduction or cessation goal, perceived cessation barriers, and medication use beliefs and behaviors. Results Survey responses indicated that efforts to develop CUD medications should focus on nonsynthetic compounds administered orally or by mouth spray no more than once per day to maximize patient acceptance. Remote adherence monitoring and one-on-one outpatient behavioral treatment approaches, especially contingency management, are also anticipated to enhance participation. Most subjects indicated a preference to reduce their cannabis use rather than quit. Conclusions These data provide guidance for the development of CUD interventions based on the preferences of individuals interested in treatment for their cannabis use. Additional research is needed to confirm these results in a larger sample and determine if matching CUD patients with their preferred treatments improves success rates.
KW - adherence
KW - behavioral therapy
KW - marijuana
KW - medication
KW - pharmacotherapy
KW - psychosocial
UR - http://www.scopus.com/inward/record.url?scp=85150172139&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85150172139&partnerID=8YFLogxK
U2 - 10.1097/ADM.0000000000001059
DO - 10.1097/ADM.0000000000001059
M3 - Article
C2 - 36731101
AN - SCOPUS:85150172139
SN - 1932-0620
VL - 17
SP - E87-E93
JO - Journal of addiction medicine
JF - Journal of addiction medicine
IS - 2
ER -